[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2826004B1 - Procede de preparation de derives estrogenes - Google Patents

Procede de preparation de derives estrogenes

Info

Publication number
FR2826004B1
FR2826004B1 FR0107711A FR0107711A FR2826004B1 FR 2826004 B1 FR2826004 B1 FR 2826004B1 FR 0107711 A FR0107711 A FR 0107711A FR 0107711 A FR0107711 A FR 0107711A FR 2826004 B1 FR2826004 B1 FR 2826004B1
Authority
FR
France
Prior art keywords
preparation
estrogenic derivatives
estrogenic
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0107711A
Other languages
English (en)
Other versions
FR2826004A1 (fr
Inventor
Francoise Benedetti
Alain Mazurie
Francois Nique
Denis Prat
Christian Wehrey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to FR0107711A priority Critical patent/FR2826004B1/fr
Priority to JP2003503646A priority patent/JP2004534796A/ja
Priority to PCT/FR2002/002001 priority patent/WO2002100880A1/fr
Priority to EP02747527A priority patent/EP1404701A1/fr
Priority to US10/480,618 priority patent/US7381718B2/en
Publication of FR2826004A1 publication Critical patent/FR2826004A1/fr
Application granted granted Critical
Publication of FR2826004B1 publication Critical patent/FR2826004B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR0107711A 2001-06-13 2001-06-13 Procede de preparation de derives estrogenes Expired - Fee Related FR2826004B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0107711A FR2826004B1 (fr) 2001-06-13 2001-06-13 Procede de preparation de derives estrogenes
JP2003503646A JP2004534796A (ja) 2001-06-13 2002-06-12 エストロゲン誘導体の製造方法
PCT/FR2002/002001 WO2002100880A1 (fr) 2001-06-13 2002-06-12 Procede de preparation de derives estrogenes
EP02747527A EP1404701A1 (fr) 2001-06-13 2002-06-12 Procede de preparation de derives estrogenes
US10/480,618 US7381718B2 (en) 2001-06-13 2002-06-12 Method for preparing oestrogen derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0107711A FR2826004B1 (fr) 2001-06-13 2001-06-13 Procede de preparation de derives estrogenes

Publications (2)

Publication Number Publication Date
FR2826004A1 FR2826004A1 (fr) 2002-12-20
FR2826004B1 true FR2826004B1 (fr) 2008-03-28

Family

ID=8864249

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0107711A Expired - Fee Related FR2826004B1 (fr) 2001-06-13 2001-06-13 Procede de preparation de derives estrogenes

Country Status (5)

Country Link
US (1) US7381718B2 (fr)
EP (1) EP1404701A1 (fr)
JP (1) JP2004534796A (fr)
FR (1) FR2826004B1 (fr)
WO (1) WO2002100880A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH1511H (en) * 1992-09-10 1995-12-05 Chappell; Charles W. Absorbent articles having improved longitudinal fluid movement
GB0307067D0 (en) 2002-12-17 2003-04-30 Aventis Pharma Inc Use of thiazolobenzoheterocycles for treating multiple sclerosis
FR2854402B1 (fr) * 2003-04-29 2008-07-04 Aventis Pharma Sa Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
WO2014093378A1 (fr) * 2012-12-10 2014-06-19 Northeastern University Agents d'imagerie d'un récepteur des œstrogènes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377419A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
FR2598421B1 (fr) * 1986-05-06 1988-08-19 Roussel Uclaf Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
FR2757519B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Steroides substitues en position 11, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2761992B1 (fr) * 1997-04-09 1999-06-11 Hoechst Marion Roussel Inc Nouveaux steroides 4-halogenes, leur procede et intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2771096B1 (fr) * 1997-11-17 2000-08-11 Hoechst Marion Roussel Inc Nouveaux 19-nor steroides, substitues en position 11beta, procede et intermediaires de preparation, application comme medicaments et compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
US7381718B2 (en) 2008-06-03
EP1404701A1 (fr) 2004-04-07
JP2004534796A (ja) 2004-11-18
US20040171595A1 (en) 2004-09-02
FR2826004A1 (fr) 2002-12-20
WO2002100880A1 (fr) 2002-12-19

Similar Documents

Publication Publication Date Title
IL146389A0 (en) Process for the preparation of dronedarone
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
FR2813077B1 (fr) Procede de preparation du citalopram
FI20010154A (fi) Menetelmä citalopramin valmistamiseksi
FR2813191B1 (fr) Derives du tocopherol et procede de preparation de ceux-ci
FR2818977B1 (fr) Procede de preparation du citalopram pur
EP1162188A4 (fr) Procede de preparation de bisphenol a
DZ3489A1 (fr) Procede de preparation de mesylates de derives de piperazine
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
FR2833596B1 (fr) Procede de preparation de derives d'echinocandine
FR2818979B1 (fr) Procede de preparation d'imidaclopride
FR2826002B1 (fr) Procede de preparation de composes bromodifluoroacetiques
NO20035586D0 (no) Fremgangsmåte for fremstilling av cykloheksanol-derivater
FR2806085B1 (fr) Procede de preparation du citalopram
EP1547993A4 (fr) Procede de preparation de spirofluorenols
FR2826004B1 (fr) Procede de preparation de derives estrogenes
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
FR2804427B1 (fr) Procede de preparation de cetones alpha-halogenees
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
EP1295864A4 (fr) Procede de preparation de 1,5-diaminonaphtalenes
EP1682627A4 (fr) Procede de preparation de methyllithium
EP1477477A4 (fr) Procede de preparation de carotenoides
FR2817550B1 (fr) Procede de preparation de derives de pyrrolidine substituee
FR2797443B1 (fr) Procede de prepartion de quinoleine-5,8-diones
FR2829759B1 (fr) Procede de preparation de polyhydroxystilbenes symetriques

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160229